FY24 earnings came in at SGD11.6mn on revenue of SGD380.4mn (-21% y/y), ahead of our expectations. FY24 revenues were back-loaded, with 2H24 revenue of SGD206.8mn (+0.4% y/y, 19.2% h/h) coming in at the higher end of the guidance of SGD190-210mn. FY24 test and automation equipment revenue grew 92% y/y to SGD105.1mn as key customer Intel pulled in orders under the non-cancellable long dated PO (purchase order) programme. However, this was unable to offset the 44% y/y decline in consumables revenue, which is due to lower utilisation and reduced design activity at Intel, as well as the c.30% y/y drop in contract manufacturing revenue on ongoing inventory digestion in industrial markets. FY24 gross margins contracted 1.2ppt y/y to 25.7% on the back of lower revenue, but AEM was able to return to profitability with net income of SGD11.6mn in FY24 in the absence of arbitration settlement expenses of SGD26.7mn recorded in the prior year.
Guidance signals a subdued 1H25, largely due to timing factors. Management guided for 1H25 revenue between SGD155-170mn, with the midpoint representing a 6% y/y decline, and accounts for c.44% of our revised FY25 revenue estimate. Reasons cited for the decline included a significant revenue pull of c.SGD50mn from FY25 to 2H24, and to a lesser extent, some customer pushouts in system shipments into 2H25.
A stronger 2H25 is expected, driven by a recovery in contract manufacturing and potential product ramp-ups. Looking ahead, we anticipate a stronger 2H25, driven by the ramp-up of key customers' devices and some recovery in the contract manufacturing segment. The AI customer’s pushout of system shipments into 2H25 also alludes to a better 2H25, given that their data centre sales will be flattish h/h in 1H25 and production ramp-ups of its upcoming product will only occur from mid-year onwards.
Customer diversification remains on track, but some patience needed as AEM lays the foundation for future growth. AEM expects revenue from new test cell solutions customers to exceed SGD100mn in FY25. We pare back our estimates for new customer contribution from SGD150mn to SGD130mn, given the cuts in consensus revenue estimates at the new fabless AI customer, which may point to lower-than-expected end volumes. Nonetheless, we see the foundation for future growth being laid with new project wins and increased engagement with new customers. Notably, there was an additional project win in 4Q24 with the AMPS-BI product slated to test next-generation standard data centre devices for the company’s new fabless AI customer. The PiXL thermal management solution is also deployed at the AI customer while the memory customer has expanded its installed base for GDDR6 device testing. Further, the market is expecting a ramp-up of AI and GDDR 7 devices in late 2025, which could potentially benefit AEM if they can service the memory customer’s GDDR7 products.
Notwithstanding shifts in order fulfilment timing, non-cancellable POs provide a lifeline for AEM, even as the key customer navigates choppy waters. Intel faces mounting pressure to improve profitability despite significant operating losses at the Intel foundry, market share erosion from intensifying competition, macroeconomic uncertainty due to tariffs, and a widening gap in the AI accelerator race. Yet, we believe that declines in contribution from the key customer will be somewhat cushioned by non-cancellable POs which work on a “take or pay” arrangement and will be drawn down through to 2H27. These non-cancellable POs mainly cover equipment and pans, which should hold up demand for those goods in the mid term. Also, the 56% h/h decline in consumables sales to SGD22.3mn in 2H24 should already be reflective of lower volumes and variants at Intel, and we believe that this should pick up across FY25 as Intel executes its product roadmap. Most of the contributions from Intel in 1H25 should therefore be from consumables and services, bearing in mind that there were substantial equipment pull-ins to 2H24.
Maintain BUY with lower TP of SGD1.69 (vs. SGD1.72 previously). We roll over our valuation to blended FY25/26F earnings to better reflect the ramp-up in new customer contributions. Our peg remains the same at 20x earnings. We reduce our FY25/26 revenue estimates by 8%/4% to reflect lower than previously expected contributions, mainly from new customers. FY25/26 earnings estimates are also reduced by 27%/17% to reflect lower margins from lower operating leverage and lower contributions from higher margin products. Overall, we believe that the foundation for future growth is being laid, but it could take some time for this to be reflected in the financials, especially given the unfavourable comparison in FY25 on a material pull-in of orders into FY24.
Access more at DBS Insights Direct
GENERAL DISCLOSURE/DISCLAIMER
The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). This report is intended for “Accredited Investors” and “Institutional Investors” (defined under the Financial Advisers Act and Securities and Futures Act of Singapore, and their subsidiary legislation), as well as “Professional Investors” (defined under the Securities and Futures Ordinance of Hong Kong) only. It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.
This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.
DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E.
DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability. 18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.
DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability. 13th Floor One Island East, 18 Westlands Road, Quarry Bay, Hong Kong SAR.